Linker-based lecithin microemulsions for transdermal delivery of lidocaine
- PMID: 17904775
- DOI: 10.1016/j.ijpharm.2007.07.047
Linker-based lecithin microemulsions for transdermal delivery of lidocaine
Abstract
In this work, we introduce alcohol-free lecithin microemulsions formulated with linkers to produce transdermal delivery vehicles. The food-grade linker system consists of a combination of sodium caprylate and caprylic acid (hydrophilic linkers), and sorbitan monooleate (lipophilic linker). A "carrier" oil (isopropyl myristate) was used to predissolve a model lipophilic drug, lidocaine. The first part of the article describes the phase behavior and physical properties of these linker-based lecithin microemulsions. In the second part of the article, we evaluate the transdermal permeation and cytotoxicity of lidocaine formulated in oil-in-water (Type I), water-in-oil (Type II), and bicontinuous (Type IV) linker microemulsions. The transdermal permeation studies show that compared to a conventional Type II alcohol-based lecithin microemulsion, Type II linker-based microemulsions provide twice the absorption and penetration of lidocaine through skin. The larger flux obtained with linker systems is due to the presence of sodium caprylate and caprylic acid. These hydrophilic linkers accelerate the microemulsion-skin mass transfer by reducing the interfacial rigidity of the systems. Furthermore, the cytotoxicity studies show that these linker microemulsions are significantly less toxic than the alcohol-based system. The Type II linker microemulsion (containing approximately 4% lidocaine) has a comparable cytotoxicity to water saturated with lidocaine (0.4% lidocaine).
Similar articles
-
Extended release of lidocaine from linker-based lecithin microemulsions.Int J Pharm. 2009 Feb 23;368(1-2):63-71. doi: 10.1016/j.ijpharm.2008.09.063. Epub 2008 Nov 1. Int J Pharm. 2009. PMID: 19010404
-
Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions.Int J Pharm. 2010 Jun 15;392(1-2):274-84. doi: 10.1016/j.ijpharm.2010.03.051. Epub 2010 Apr 2. Int J Pharm. 2010. PMID: 20363304
-
Lecithin-linker formulations for self-emulsifying delivery of nutraceuticals.Int J Pharm. 2014 Aug 25;471(1-2):92-102. doi: 10.1016/j.ijpharm.2014.05.001. Epub 2014 May 6. Int J Pharm. 2014. PMID: 24810240
-
Microemulsions as transdermal drug delivery vehicles.Adv Colloid Interface Sci. 2006 Nov 16;123-126:369-85. doi: 10.1016/j.cis.2006.05.014. Epub 2006 Jul 14. Adv Colloid Interface Sci. 2006. PMID: 16843424 Review.
-
Influence of microemulsions on cutaneous drug delivery.Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S77-98. doi: 10.1016/s0169-409x(02)00116-3. Adv Drug Deliv Rev. 2002. PMID: 12460717 Review.
Cited by
-
Development of an in Vitro System to Simulate the Adsorption of Self-Emulsifying Tea (Camellia oleifera) Seed Oil.Molecules. 2016 Apr 29;21(5):479. doi: 10.3390/molecules21050479. Molecules. 2016. PMID: 27136528 Free PMC article.
-
Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery.Pharmaceuticals (Basel). 2022 Apr 22;15(5):515. doi: 10.3390/ph15050515. Pharmaceuticals (Basel). 2022. PMID: 35631342 Free PMC article.
-
Microemulsions and Nanoemulsions in Skin Drug Delivery.Bioengineering (Basel). 2022 Apr 5;9(4):158. doi: 10.3390/bioengineering9040158. Bioengineering (Basel). 2022. PMID: 35447718 Free PMC article. Review.
-
Safety and efficacy concerns of modern strategies of local anesthetics delivery.3 Biotech. 2020 Aug;10(8):333. doi: 10.1007/s13205-020-02309-y. Epub 2020 Jul 6. 3 Biotech. 2020. PMID: 32656066 Free PMC article. Review.
-
Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole.AAPS PharmSciTech. 2015 Aug;16(4):889-904. doi: 10.1208/s12249-014-0275-8. Epub 2015 Jan 16. AAPS PharmSciTech. 2015. PMID: 25591952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
